Withania somnifera/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases malondialdehyde (circulating)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“All doses of AE (SD + A1 to SD + A4) reduced serum, liver, and brain MDA levels compared to those in non-supplemented rats (p < 0.01, Figure 4).”
Quoted verbatim from A Novel Ashwagandha (Withania somnifera) Formulation Mitigates Sleep Deprivation-Induced Cognitive Impairment and Oxidative Stress in a Rat Model.. - Study
- animal · not in humans
- Duration
- 4 weeks
- Dose
- 15 or 30 mg/kg of 1.5% extract, or 5.5 or 11 mg/kg of 8% extract, once daily by oral gavage
- Population
- Male Sprague-Dawley rats (n = 7 per group) subjected to sleep deprivation for 4 weeks; comparison is against sleep-deprived rats given saline; all four AE dose groups pooled in the sentence
A Novel Ashwagandha (Withania somnifera) Formulation Mitigates Sleep Deprivation-Induced Cognitive Impairment and Oxidative Stress in a Rat Model.2025PMID:40427603An author is affiliated with a producerPermalink
Keep reading
- Everything the graph holds on Withania somnifera
- Every compound studied against Malondialdehyde (circulating)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PZSAHK6CVVJB3FTNHN21V7